Rezultati - Suzanne Travers
- Showing 1 - 4 results of 4
-
1
Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease od Stephen B. Hanauer, Carrie Wagner, Mohan Bala, Lloyd Mayer, Suzanne Travers, Robert H. Diamond, Allan Olson, Warren Bao, Paul Rutgeerts
Izdano 2004Artigo -
2
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children od Jeffrey S. Hyams, Wallace Crandall, Subra Kugathasan, Anne M. Griffiths, Allan Olson, Jewel Johanns, Grace Liu, Suzanne Travers, Robert Heuschkel, James Markowitz, Stanley A. Cohen, Harland S. Winter, G. Veereman‐Wauters, George D. Ferry, Robert N. Baldassano
Izdano 2006Artigo -
3
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis od Paul Rutgeerts, William J. Sandborn, Brian G. Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen B. Hanauer, Gary R. Lichtenstein, Willem J.S. de Villiers, Daniel H. Present, Bruce E. Sands, Jean‐Frédéric Colombel
Izdano 2005Artigo -
4
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease od Bruce E. Sands, Frank Anderson, Çharles N. Bernstein, William Y. Chey, Brian G. Feagan, Richard N. Fedorak, Michael A. Kamm, Joshua R. Korzenik, Bret A. Lashner, Jane E. Onken, Daniel Rachmilewitz, Paul Rutgeerts, Gary Wild, Douglas C. Wolf, P Marsters, Suzanne Travers, Marion Blank, S J van Deventer
Izdano 2004Artigo
Iskalna orodja:
Sorodne teme
Disease
Gastroenterology
Infliximab
Internal medicine
Medicine
Surgery
Alternative medicine
Chemotherapy
Crohn's disease
Maintenance therapy
Pathology
Placebo
Randomized controlled trial
Antibody
Confidence interval
Environmental health
Immunology
Incidence (geometry)
Inflammatory bowel disease
Optics
Physics
Population
Randomization
Regimen
Tumor necrosis factor alpha
Ulcerative colitis